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Abstract In this report, cell-cycle-dependent effects of TFIID 
on other basal transcription factors were investigated. We 
purified TFIID fractions from HeLa cells synchronized in the 
S/G2 phases and in early Gl phase, and show that RAP74 is 
phosphorylated more highly by the S/G2 phase TFIID fraction 
than by the early Gl phase TFIID fraction. Further analyses 
using deletion mutants of RAP74 revealed that amino acid 
residues 206-256 are phosphorylated by the TFIID fraction. 
Reconstitution of in vitro transcription activity indicates that the 
cell-cycle-dependent phosphorylation of RAP74 increases TFIIF 
transcription activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The eukaryotic cell cycle is a highly regulated process that is 
dependent on the temporal expression of specific genes. The 
cloning of TAFn250 [1,2], the largest subunit of T F I I D , has 
provided a link between cell cycle regulation and the basal 
transcription machinery. T A F n 2 5 0 is encoded by C C G 1 , a 
gene that overcomes a G l arrest in the temperature-sensitive 
hamster cell line t s l3 [3,4]. Therefore T A F n 2 5 0 may be re-
quired for progression through the G l phase and may be 
involved in cell cycle control. 
We have previously investigated in vitro R N A polymerase 
II (pol II) basal transcription activity during the cell cycle by 
using nuclear extracts from synchronized HeLa cells and 
showed that the activity is low in the S/G2 phases and high 
in the early G l phase [5]. Fur ther analyses revealed that 
T F I I D is the rate-limiting component for this difference and 
a qualitative change of T F I I D and protein-protein interac-
tions between T F I I D and other transcription factors may 
play an important role in cell-cycle-dependent basal transcrip-
tion activity. In this report, the cell-cycle-dependent effects of 
T F I I D on other basal transcription factors were investigated. 
We prepared T F I I D fractions from HeLa cells synchronized 
in the S/G2 phases and early G l phase, and found that 
RAP74, a large subunit of T F I I F , is phosphorylated more 
highly by the S/G2 phase T F I I D fraction than by the early 
G l phase T F I I D fraction. Interestingly, Dikstein et al. [6] 
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reported recently that TAFn250 is a protein serine kinase 
that selectively phosphorylated RAP74. 
T F I I F [7,8], also termed F C [9], RAP30/74 [10], Py in rat 
[11], or factor 5 in Drosophila [12], is a heterodimer composed 
of ~ 3 0 k D a (RAP30) and ~ 7 0 k D a (RAP74) subunits [8-
10]. T F I I F can bind pol II directly [7,9,10] and recruits the 
enzyme to a preformed D N A - T F I I D - T F I I B complex [7]. Fur-
thermore, T F I I F also stimulates the elongation of nascent 
m R N A by pol II [7,12,13]. Native T F I I F subunits have a 
lower mobility than the bacterially expressed recombinant 
proteins on SDS-PAGE [14], indicating that T F I I F is post-
translationally modified in vivo. In experiments in our labo-
ratory, RAP74 was extensively phosphorylated in vivo and 
T F I I F transcription activity was up-regulated by protein 
phosphorylation of RAP74 [15]. Consistent with this, it is 
shown that the cell-cycle-dependent phosphorylation of 
RAP74 by T F I I D fraction increases T F I I F transcription ac-
tivity. 
2. Materials and methods 
2.1. Cell synchronization and extract preparation 
HeLa S3 cells were grown at 37°C in RPMI medium with 10% fetal 
bovine serum in dishes (245X245X25 mm) at a density of 1-8x10° 
cells/ml. These cells were synchronized at the Gl -S phase boundary 
by the double thymidine block protocol [16] with minor modifications 
[5]. Log phase cells were incubated in complete medium with addition 
of 2 mM thymidine for 16 h. After release in thymidine-free medium 
for 8 h the cells were incubated again with 2 mM thymidine for 16 h. 
After release in thymidine-free medium the cells were harvested at 
8 and 12 h. Monitoring of the synchronization has been described 
before [5]. Nuclear extracts were prepared as described by Dignam 
et al. [17] with minor modifications as described before [5]. 
2.2. Purification of TFIID fraction and recombinant TFIIF 
Nuclear extracts were applied to a phosphocellulose (PI 1, What-
man) column equilibrated with buffer D. After washing the column 
with buffer D containing 0.5 M KC1, TFIID was eluted stepwise by 
buffer D containing 0.7 M KC1. Recombinant RAP30, recombinant 
RAP74, and deletion mutants of RAP74 were expressed in E. coli and 
purified as described before [14]. Recombinant RAP74 was expressed 
with E. coli chaperon GroESL to increase solubility of RAP74 [18]. 
2.3. In vitro kinase assay 
TFIID fraction was incubated with 50 ng of recombinant RAP74 at 
30°C for 30 min in 10 [0.1 of kinase buffer containing 25 mM HEPES 
(pH 7.9), 12.5 mM MgCl2, 0.1 M KC1, 0.1 mM EDTA, 0.1% NP-40, 
and 3 u.Ci [y-32P]ATP. The reactions were stopped by the addition of 
protein sample buffer followed by SDS-PAGE and autoradiography 
for 3-15 min. 
2.4. In vitro transcription assay 
In vitro transcription activity of phosphorylated recombinant 
RAP74 was assayed as before [9,19] with minor modifications. 50 
ng of recombinant RAP74 was phosphorylated by 5 ng of the S/G2 
phase TFIID fraction and by 5 ng of the early Gl phase LFIID 
fraction. A mixture of 50 ng of phosphorylated recombinant RAP74 
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and 50 ng of recombinant RAP30 was first incubated at 30°C for 30 
min in 20 ul. The reaction was performed in a total of 20 jxl contain-
ing 0.1 ng of preincubated TFIIF, 10 ng of TATA box binding pro-
tein (TBP), 20 ng of TFIIB, 0.4 ug of FE (a mixture of TFIIE and 
TFIIH), 0.8 ug of the D1P2 fraction (a crude fraction containing FA 
and FB according to our nomenclature; see Ref. [20]), and 0.5 ug of 
RNA polymerase II using 2 ug of pMLC2AT-A50 [21] which contains 
the region —50 to +10 of Ad2MLP and a downstream G-less cassette. 
The above mixture was incubated for the assembly of the initiation 
complex at 30°C for 30 min, and nucleoside triphosphates were added 
to a final concentration of 600 uM for ATP and CTP and 25 uM for 
UTP (5 uCi). After 60 min, the reaction was stopped and radioactive 
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Fig. 2. In vitro kinase assays with deletion mutants of RAP74. A: 
Various deletion mutants of RAP74 were analyzed on 10% SDS-
PAGE and stained by silver stain. Lane 1, wild type; lane 2, r74(l-
435); lane 3, r74(l-356); lane 4, r74(l-256); lane 5, r74(l-205); 
lane 6, r74(205-517); lane 7, r74(356-517). B: In vitro kinase assays 
with various deletion mutants of RAP74 in the S/G2 phase TFIID 
fraction. Lanes 1-7 are the same as (A). C: Evolutionary conserva-
tion of serine residues in amino acids 217-224 acids of RAP74. Hu-
man RAP74 (h RAP74) [19,22] is compared with Xenopus RAP74 
(x RAP74) [23] and Drosophila Factor 5a (d F5a) [24,25]. Serine res-
idues are boxed. 
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Fig. 1. In vitro kinase assays with recombinant RAP74 in the S/G2 
phase TFIID fraction and in the early Gl phase TFIID fraction. 
A: 2 ug of the S/G2 phase TFIID fraction (lane 1), 2 ug of the 
early Gl phase TFIID fraction (lane 2), and 50 ng of recombinant 
RAP74 (lane 3) were analyzed on 7% SDS-PAGE and stained by 
silver staining. B: In vitro kinase assays were performed with 50 ng 
of recombinant RAP74 in 0.5 ng (lane 1) and 5 ng (lane 3) of the 
S/G2 phase TFIID fraction, and in 0.5 ng (lane 2) and 5 ng (lane 
4) of the early Gl phase TFIID fraction. Arrow indicates RAP74. 
RNA was isolated. RNA transcripts were analyzed on 6% polyacryl-
amide-7M urea gel. 
3. Results 
HeLa S3 cells were synchronized at the G l - S phase boun-
dary by double thymidine block. The effectiveness of this syn-
chronization was monitored before [5] and the cells were 
found to be predominantly in the S/G2 phases and early G l 
phase at 8 and 12 h after release from the thymidine block, 
respectively. Nuclear extracts were prepared from cells 
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Fig. 3. In vitro transcription activity of phosphorylated RAP74. Re-
constitution of in vitro transcription using phosphorylated RAP74 
was assayed as described in Section 2. Lane 1, phosphorylated 
RAP74 by the S/G2 phases TFIID fraction; lane 2, phosphorylated 
RAP74 by the early Gl phase TFIID fraction; lane 3, unphos-
phorylated RAP74. 
synchronized at 8 and 12 h after release and TFIID fractions 
were subjected to partial purification at each time point. Fig. 
1A shows the S/G2 phase TFIID fraction (lane 1) and the 
early Gl phase fraction (lane 2). Although we performed in 
vitro kinase assays with recombinant TBP, TFIIB, and 
RAP30, the TFIID fractions did not phosphorylate these pro-
teins (data not shown). In contrast, recombinant RAP74 was 
phosphorylated by the TFIID fractions and the kinase activity 
was significantly higher in the S/G2 phase fraction than in the 
early Gl phase fraction upon the use of the same concentra-
tion of the TFIID fractions (Fig. IB). 
To investigate the phosphorylated region of RAP74, C-ter-
minal deletion mutants containing the C-terminal sequence 
deleted down to amino acids 435, 356, 256 and 205, and N-
terminal deletion mutants containing N-terminal sequence de-
leted down to residues 205 and 356 were prepared (Fig. 2A). 
Fig. 2B shows in vitro kinase assay with these deletion mu-
tants in the S/G2 phase TFIID fraction. Although r74(1^135), 
r74(l-356), r74(l-256), and r74(205-517) were phosphoryl-
ated, r74(l-205) and r74(356-517) were not. Therefore the 
TFIID fraction phosphorylates amino acid residues 206-256 
of RAP74. Amino acid residues 206-256 contain 5 serine res-
idues and do not contain any threonine or tyrosine residues. 
Particularly amino acid residues 217-224 have a cluster of 
serine residues (Fig. 2C). Comparison with human RAP74 
[19,22], Xenopus RAP74 [23], and Drosophila Factor 5a 
[24,25] shows that these serine residues may be highly con-
served during evolution. Therefore it is highly likely that the 
serine residues in amino acids 217-224 are phosphorylated by 
TFIID in a cell-cycle-dependent manner. 
We have previously reported that RAP74 is extensively 
phosphorylated in vivo and that TFIIF transcription activity 
is up-regulated by protein phosphorylation of RAP74 [15]. To 
analyze the effect of the cell-cycle-dependent phosphorylation 
of RAP74 on pol II basal transcription activity, reconstitution 
of in vitro transcription activity using the phosphorylated re-
combinant RAP74 was performed. Fig. 3 shows that phos-
phorylated RAP74 by the early Gl phase TFIID fraction 
(lane 2) had stronger activity than unphosphorylated RAP74 
(lane 3) and that high-phosphorylated RAP74 by the S/G2 
phase fraction (lane 1) had the strongest activity. These data 
indicate that the cell-cycle-dependent phosphorylation of 
RAP74 increases the in vitro transcription activity. 
4. Discussion 
In this report, cell-cycle-dependent effects of TFIID on oth-
er basal transcription factors were investigated. We prepared 
TFIID fractions from HeLa cells synchronized in the S/G2 
phases and early Gl phase, and found that RAP74 is phos-
phorylated more highly by the S/G2 phases TFIID fraction 
than by the early Gl phase TFIID fraction. In experiments in 
our laboratory, RAP74 was extensively phosphorylated in 
vivo but RAP30 was not and TFIIF transcription initiation 
and elongation activities were up-regulated by protein phos-
phorylation of RAP74 [15]. Consistent with this, it was shown 
that the cell-cycle-dependent phosphorylation of RAP74 in-
creases the in vitro transcription activity. Also, we have pre-
viously reported that in vitro pol II basal transcription activ-
ity is low in the S/G2 phases and high in the early Gl phase 
[5]. The changes in TFIIF activity and basal transcription 
activity during the cell cycle are quite opposite. In our former 
report [5], post-translationally modified recombinant TFIIF is 
not the rate-limiting step for the change of transcription ac-
tivity, indicating that phosphorylated TFIIF activity does not 
have a dominant effect on pol II basal transcription activity 
during the cell cycle. 
RAP74 is proposed to be structurally separated into three 
regions—a globular N-terminal domain (1-179), a charged 
domain (180-356), and a globular C-terminal domain (357-
517) [19,22]. The N-terminal region is important for RAP30 
binding [14,26] and the C-terminal region contributes to tran-
scription activity [14,26,27]. The internal region of RAP74 
carries three multiple charge clusters and three hyper-charge 
runs [28]. Multiple charge clusters and hyper-charge runs are 
rare sequence features occurring in < 4 % of all eukaryotic 
proteins. It was proposed that the distinguishing charge fea-
tures are related to interactions with nucleic acids and other 
proteins in the initiation and processing of the transcription 
apparatus. Also several possible phosphorylation sites for 
many protein kinases including casein kinase II, protein kin-
ase C, and protein kinase A have been found along with the 
charge clusters [19]. In this report, it was shown that the 
TFIID fraction phosphorylates amino acid residues 206-256 
which is in the central charged domain of RAP74. This result 
suggests that cell-cycle-dependent phosphorylation affects the 
assembly and function of the pol II initiation and/or elonga-
tion complex. Next, amino acid residues 206-256 contain 
5 serine residues and do not contain any threonine or tyrosine 
residues. Particularly amino acid residues 217-224 have a clus-
ter of serine residues and the serine residues may be highly 
conserved during evolution (Fig. 2C). Therefore it is highly 
likely that the serine residues in amino acids 217-224 are 
phosphorylated by TFIID in a cell-cycle-dependent manner. 
TAFn250 [1,2], the largest subunit of TFIID, rescues the 
temperature-sensitive hamster cell line, tsl3, and overcomes a 
Gl arrest. Therefore TAFn250 may be required for progres-
sion through the Gl phase and may be involved in cell cycle 
control. Recently Dikstein et al. [6] reported that TAFn250 is 
a protein serine kinase that selectively phosphorylates RAP74 
but not other basal transcription factors and that N- and C-
terminal domains of TAFn250 are required for efficient trans-
phosphorylation of RAP74. It is possible that TAFn250 phos-
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phorylates the serine residues in amino acids 217-224 of 
RAP74 in a cell-cycle-dependent manner. Fur thermore, Rup-
pert and Tjian [29] reported that human TAFn250 interacts 
with RAP74 and that the RAP74 binding region of T A F n 2 5 0 
is required to rescue t s l 3 cells. Therefore the cell-cycle-de-
pendent phosphorylation of RAP74 may play an important 
role in cell cycle progression. 
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